Hope Biosciences announces FDA approval on their third clinical trial for COVID-19. This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics. The hospital has an entire floor dedicated to treating COVID-19 patients, with staff specifically trained to care for these patients. The goal of this collaboration is to provide cutting-edge therapeutic interventions, like Hope Biosciences’ adipose-derived mesenchymal stem cells (HB-adMSCs), in a safe, efficient environment to provide the best care to COVID-19 patients.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,